Testosterone Therapy and Back Acne
Testosterone replacement therapy (TRT) is a cornerstone treatment for men with hypogonadism. It improves energy, libido, mood, muscle mass, and overall quality of life. But one predictable—and often under-discussed—side effect is acne.
For prescribers, this creates a practical issue: patients feel better systemically but may become frustrated with new or worsening skin problems. The solution isn’t stopping TRT—it’s managing the downstream effects appropriately.
Why Testosterone Causes Acne
Acne related to TRT is not random—it’s mechanistically predictable.
Increased Sebum Production
Testosterone is converted in the skin to dihydrotestosterone (DHT), which directly stimulates sebaceous glands. More sebum = higher risk of clogged pores and acne formation.
Follicular Hyperkeratinization
Androgens increase keratinocyte turnover inside hair follicles, leading to blockage. This creates the environment for comedones (blackheads/whiteheads).
Bacterial Proliferation
Excess sebum promotes growth of Cutibacterium acnes. Triggers inflammation and inflammatory acne lesions.
Dose & Delivery Dependence
Higher serum peaks—especially with injectable testosterone—can worsen acne severity. Fluctuations matter, not just total dose.
How Common Is Acne with TRT?
- Acne is one of the most frequently reported dermatologic side effects of testosterone therapy.
- Incidence varies, but studies suggest:
- Up to 50% of patients may experience some degree of acne
- Higher rates in younger men and those prone to acne historically
Clinical takeaway: If you prescribe TRT, you should expect acne in a meaningful percentage of patients.
Why This Matters Clinically
Patients don’t discontinue TRT because it “doesn’t work”—they stop because of side effects they weren’t prepared for.
Acne can:
- Reduce adherence to therapy
- Impact patient confidence and satisfaction
- Lead to unnecessary dose reductions or discontinuation
Bottom line: Managing acne proactively protects both outcomes and retention.
Treatment Strategy: Don’t Stop TRT—Treat the Skin
For most patients, acne associated with TRT is manageable with appropriate topical therapy.
First-Line: Combination Topical Therapy
A compounded formulation like:
Niacinamide 3% / Clindamycin 1.2% / Tretinoin 0.025% Gel
targets all three major drivers of acne:
Component
Mechanism
Clinical Benefit
Niacinamide
Anti-inflammatory, reduces sebum
Decreases redness and oiliness
Clindamycin
Antibacterial
Reduces C. acnes colonization
Tretinoin
Normalizes keratinization
This is not random stacking—it’s a rational, multi-pathway approach.
Why Prescribers Choose Compounded Combinations
1. Simplified Regimen = Better Compliance
One product vs. three separate prescriptions improves adherence.
2. Customizable Strengths
Allows titration based on:
- Skin sensitivity
- Acne severity
- Patient history
3. Reduced Irritation Potential
Balanced formulations can mitigate the irritation commonly seen with standalone retinoids.
When to Consider Prescribing Acne Therapy with TRT
You don’t need to wait for acne to appear. Consider proactive prescribing in:
- Younger men starting TRT
- Patients with a history of acne
- Patients on injectable testosterone (higher peaks)
- Higher-dose TRT protocols
Practical approach:
Set expectations + prescribe early = fewer callbacks and better patient satisfaction.
Key Takeaways for Prescribers
- Acne with TRT is expected, not incidental
- It is driven by androgen-mediated sebum production and follicular changes
- Stopping testosterone is rarely necessary
- Combination topical therapy addresses the root causes efficiently
- Proactive management improves adherence, satisfaction, and outcomes
How To Prescribe
Visit the Practitioner Portal to download a prescription blank for Niacinamide 3% / Clindamycin 1.2% / Tretinoin 0.025% Gel.
Supporting Clinical Evidence
Androgens and Acne Pathophysiology
- Thiboutot D, et al. Endocrine Reviews. 2009.
- Demonstrates androgen-driven sebaceous gland activity and acne development.
Testosterone Therapy and Dermatologic Effects
- Bhasin S, et al. Journal of Clinical Endocrinology & Metabolism. 2018.
- Clinical practice guideline noting acne as a common adverse effect of TRT.
Topical Retinoids and Combination Therapy
- Zaenglein AL, et al. Journal of the American Academy of Dermatology. 2016.
- Recommends combination therapy (retinoid + antimicrobial) as standard of care.
Clindamycin + Tretinoin Efficacy
- Leyden JJ, et al. Journal of Drugs in Dermatology. 2006.
- Combination therapy more effective than monotherapy in inflammatory acne.
Niacinamide in Acne
- Draelos ZD. Journal of Cosmetic Dermatology. 2006.
- Demonstrates anti-inflammatory and sebum-reducing effects of niacinamide.